CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-007667
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Melanoma-associated antigen 2 
Protein Synonyms/Alias
 Cancer/testis antigen 1.2; CT1.2; MAGE-2 antigen 
Gene Name
 MAGEA2; MAGEA2B 
Gene Synonyms/Alias
 MAGE2; MAGEA2A; MAGE2; MAGEA2 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
132RAREPVTKAEMLESVubiquitination[1, 2]
244SVFAHPRKLLMQDLVubiquitination[1, 2]
Reference
 [1] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [2] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.
 Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW.
 Nature. 2013 Apr 18;496(7445):372-6. [PMID: 23503661
Functional Description
 Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T- lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation. 
Sequence Annotation
 DOMAIN 109 308 MAGE.  
Keyword
 Complete proteome; Nucleus; Reference proteome; Transcription; Transcription regulation; Tumor antigen; Ubl conjugation pathway. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 314 AA 
Protein Sequence
MPLEQRSQHC KPEEGLEARG EALGLVGAQA PATEEQQTAS SSSTLVEVTL GEVPAADSPS 60
PPHSPQGASS FSTTINYTLW RQSDEGSSNQ EEEGPRMFPD LESEFQAAIS RKMVELVHFL 120
LLKYRAREPV TKAEMLESVL RNCQDFFPVI FSKASEYLQL VFGIEVVEVV PISHLYILVT 180
CLGLSYDGLL GDNQVMPKTG LLIIVLAIIA IEGDCAPEEK IWEELSMLEV FEGREDSVFA 240
HPRKLLMQDL VQENYLEYRQ VPGSDPACYE FLWGPRALIE TSYVKVLHHT LKIGGEPHIS 300
YPPLHERALR EGEE 314 
Gene Ontology
 GO:0016605; C:PML body; IDA:UniProtKB.
 GO:0042826; F:histone deacetylase binding; IDA:UniProtKB.
 GO:0070491; F:repressing transcription factor binding; IDA:UniProtKB.
 GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB.
 GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB.
 GO:0090398; P:cellular senescence; IDA:UniProtKB.
 GO:1901984; P:negative regulation of protein acetylation; IDA:UniProtKB.
 GO:0033234; P:negative regulation of protein sumoylation; IDA:UniProtKB.
 GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
 GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:UniProtKB.
 GO:0072331; P:signal transduction by p53 class mediator; IDA:UniProtKB.
 GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. 
Interpro
 IPR002190; MAGE.
 IPR021072; Melanoma_ass_antigen_N. 
Pfam
 PF01454; MAGE
 PF12440; MAGE_N 
SMART
  
PROSITE
 PS50838; MAGE 
PRINTS